Aquatic Capital Management’s NovoCure NVCR Stock Holding History

Aquatic Capital Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$595K	Buy	39,262 +25,566	+187%	+$387K	0.02%	735
2026 Q1	$149K	Sell	13,696 -69,990	-84%	-$874K	﹤0.01%	1040
2025 Q4	$1.08M	Buy	83,686 +3,517	+4%	+$45.1K	0.03%	526
2025 Q3	$1.04M	Buy	80,169 +18,197	+29%	+$243K	0.02%	663
2025 Q2	$1.1M	Buy	61,972 +15,662	+34%	+$273K	0.02%	624
2025 Q1	$825K	Buy	+46,310	New	+$1.05M	0.02%	645
2024 Q4	–	Sell	-59,500	Closed	-$930K	–	1533
2024 Q3	$930K	Buy	+59,500	New	+$1.08M	0.02%	516
2024 Q1	–	Sell	-35,200	Closed	-$526K	–	1508
2023 Q4	$526K	Buy	35,200 +19,800	+129%	+$265K	0.01%	625
2023 Q3	$249K	Buy	15,400 +9,200	+148%	+$265K	0.01%	630
2023 Q2	$257K	Buy	+6,200	New	+$385K	0.01%	605
2023 Q1	–	Sell	-11,700	Closed	-$858K	–	1606
2022 Q4	$858K	Buy	+11,700	New	+$880K	0.06%	358
2022 Q2	–	Sell	-100	Closed	-$8K	–	1459
2022 Q1	$8K	Sell	100 -200	-67%	-$14.7K	0.01%	732
2021 Q4	$23K	Buy	+300	New	+$30.1K	0.04%	556

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Aquatic Capital Management's NVCR Position: Q2 2026 in Review

Aquatic Capital Management increased its NovoCure (NVCR) stake by 187% in Q2 2026, buying an estimated $387K and bringing the position to 39,262 shares worth $595K. The position accounts for 0.02% of the portfolio, ranked #735.

Aquatic Capital Management first reported a position in NVCR in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.1M in Q2 2025. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Aquatic Capital Management held 39,262 shares of NovoCure worth $595K as of Q2 2026.
Aquatic Capital Management bought 25,566 NovoCure shares in Q2 2026, an estimated $387K.
NovoCure made up 0.02% of Aquatic Capital Management's portfolio in Q2 2026, its #735 holding.
Aquatic Capital Management first reported a position in NovoCure in Q4 2021 and has held it in 13 quarters since.
Aquatic Capital Management's NovoCure position peaked at $1.1M in Q2 2025.
216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.